{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T03:47:30Z","timestamp":1782100050018,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00210-026-05077-3","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T06:38:13Z","timestamp":1770446293000},"page":"10655-10668","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Barriers to effective hypertension control in a low-income healthcare setting: The role of therapeutic inertia and its predictors among hypertensive outpatients"],"prefix":"10.1007","volume":"399","author":[{"given":"Ejigayehu Getahun","family":"Ganamo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawit Alemu","family":"Lemma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Temesgen Bati","family":"Gelgelu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zewde Zema","family":"Kanche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"key":"5077_CR1","volume":"11","author":"AAL Ajayi","year":"2021","unstructured":"Ajayi AAL, Ajayi OE (2021) Pathophysiologically based antihypertensive pharmacotherapeutics rationality, efficacy and safety in Sub Saharan African Nations - a review. Int J Cardiol Cardiovasc Risk Prev 11:200111","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"issue":"1","key":"5077_CR2","first-page":"19","volume":"12","author":"K Aldona","year":"2017","unstructured":"Aldona K, Agata K, Piotr M, \u0141ukasz P, Aleksandra J, Marzena W et al (2017) The Adherence in Chronic Diseases Scale \u2014 a new tool to monitor implementation of a treatment plan. Folia Cardiol 12(1):19\u201326","journal-title":"Folia Cardiol"},{"issue":"6","key":"5077_CR3","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1097\/HJH.0000000000002783","volume":"39","author":"DH Ali","year":"2021","unstructured":"Ali DH, Kili\u00e7 B, Hart HE, Bots ML, Biermans MCJ, Spiering W et al (2021) Therapeutic inertia in the management of hypertension in primary care. J Hypertens 39(6):1238\u20131245","journal-title":"J Hypertens"},{"key":"5077_CR4","doi-asserted-by":"crossref","unstructured":"Alonso-Moreno FJ, Llisterri Caro JL, Rodr\u00edguez-Roca GC, Ferreiro Madue\u00f1o M, Gonz\u00e1lez-Segura Alsina D, Divis\u00f3n Garrote JA et al (2008) [Primary care physicians behaviour on hypertensive patients with poor blood pressure control. The PRESCAP 2006 study]. Rev Clin Esp 208(8):393\u20139","DOI":"10.1157\/13126341"},{"issue":"1","key":"5077_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semerg.2012.05.007","volume":"39","author":"FJ Alonso Moreno","year":"2013","unstructured":"Alonso Moreno FJ, Llisterri Caro JL, Rodr\u00edguez Roca GC, Prieto D\u00edaz MA, Divis\u00f3n Garrote JA, Barrios Alonso V et al (2013) Medical conduct in primary care as regards blood pressure control. PRESCAP 2010 study. Semergen 39(1):3\u201311","journal-title":"Semergen"},{"issue":"1","key":"5077_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1161\/HYPERTENSIONAHA.121.18192","volume":"79","author":"A Al-Makki","year":"2022","unstructured":"Al-Makki A, DiPette D, Whelton PK, Murad MH, Mustafa RA, Acharya S et al (2022) Hypertension pharmacological treatment in adults: a World Health Organization guideline executive summary. Hypertension 79(1):293\u2013301","journal-title":"Hypertension"},{"key":"5077_CR7","doi-asserted-by":"crossref","unstructured":"Barro M, Yam\u00e9ogo AR, Mba RD, Kabor\u00e9 R, Mandi G, Dahourou DL et al (2022) Modelling factors associated with therapeutic inertia in hypertensive patients: analysis using repeated data from a hospital registry in West Africa. Medicine (Baltimore) 101(49):e31147","DOI":"10.1097\/MD.0000000000031147"},{"issue":"11","key":"5077_CR8","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.jacc.2018.07.008","volume":"72","author":"RM Carey","year":"2018","unstructured":"Carey RM, Muntner P, Bosworth HB, Whelton PK (2018) Prevention and control of hypertension: JACC health promotion series. J Am Coll Cardiol 72(11):1278\u20131293","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"5077_CR9","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/jch.14699","volume":"25","author":"C Darricarrere","year":"2023","unstructured":"Darricarrere C, Jacquot E, Bricout S, Louis C, B\u00e9nard M, Poulter NR (2023) Uncontrolled blood pressure and therapeutic inertia in treated hypertensive patients: a retrospective cohort study using a UK general practice database. J Clin Hypertens (Greenwich) 25(10):895\u2013904","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"4","key":"5077_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248471","volume":"16","author":"T De Backer","year":"2021","unstructured":"De Backer T, Van Nieuwenhuyse B, De Bacquer D (2021) Antihypertensive treatment in a general uncontrolled hypertensive population in Belgium and Luxembourg in primary care: therapeutic inertia and treatment simplification. The SIMPLIFY study. PLoS One 16(4):e0248471","journal-title":"PLoS One"},{"issue":"1","key":"5077_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-40820-3","volume":"13","author":"A Dehghan","year":"2023","unstructured":"Dehghan A, Rezaei F, Aune D (2023) A comparative assessment between Globorisk and WHO cardiovascular disease risk scores: a population-based study. Sci Rep 13(1):14229","journal-title":"Sci Rep"},{"issue":"6","key":"5077_CR12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/jch.12095","volume":"15","author":"N Desai","year":"2013","unstructured":"Desai N, Madhavankutty Saraswathy V, Hunter K, Mcfadden C (2013) Prevalence of true therapeutic inertia in blood pressure control in an academic chronic kidney disease clinic. J Clin Hypertens 15(6):375\u2013379","journal-title":"J Clin Hypertens"},{"issue":"12","key":"5077_CR13","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.aprim.2010.09.030","volume":"43","author":"CS Dom\u00e9nech","year":"2011","unstructured":"Dom\u00e9nech CS, Caro JLL, Sanz VP, Moreno FJA, Rodr\u00edguez IL, Loro AN et al (2011) Objective KONTROL study: therapeutic inertia in hypertensive patients attended in primary care of Spain. Aten Primaria 43(12):638\u2013647","journal-title":"Aten Primaria"},{"issue":"1","key":"5077_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3109\/08037050903350762","volume":"19","author":"V Gil-Guill\u00e9n","year":"2010","unstructured":"Gil-Guill\u00e9n V, Orozco-Beltrn D, P\u00e9rez RP, Alfonso JL, Redn J, Pertusa-Martnez S et al (2010a) Clinical inertia in diagnosis and treatment of hypertension in primary care: Quantification and associated factors. Blood Press 19(1):3\u201310","journal-title":"Blood Press"},{"issue":"12","key":"5077_CR15","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2165\/11596640-000000000-00000","volume":"28","author":"V Gil-Guill\u00e9n","year":"2011","unstructured":"Gil-Guill\u00e9n V, Orozco-Beltr\u00e1n D, M\u00e1rquez-Contreras E, Durazo-Arvizu R, Cooper R, Pita-Fern\u00e1ndez S et al (2011) Is there a predictive profile for clinical inertia in hypertensive patients? An observational, cross-sectional, multicentre study. Drugs Aging 28(12):981\u2013992","journal-title":"Drugs Aging"},{"issue":"9","key":"5077_CR16","doi-asserted-by":"publisher","first-page":"412","DOI":"10.4140\/TCP.n.2022.412","volume":"37","author":"R Ginzburg","year":"2022","unstructured":"Ginzburg R, Hilas O (2022) Addressing clinical and therapeutic inertia through comprehensive medication review. Sr Care Pharm 37(9):412\u2013420","journal-title":"Sr Care Pharm"},{"issue":"4","key":"5077_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.hipert.2022.09.002","volume":"39","author":"M Gorostidi","year":"2022","unstructured":"Gorostidi M, Gij\u00f3n-Conde T, de la Sierra A, Rodilla E, Rubio E, Vinyoles E et al (2022) 2022 Practice guidelines for the management of arterial hypertension of the Spanish Society of Hypertension. Hipertens y Riesgo Vasc 39(4):174\u2013194","journal-title":"Hipertens y Riesgo Vasc"},{"key":"5077_CR18","doi-asserted-by":"crossref","unstructured":"Greenwood DA, Peeples M (2019) Technology to overcome therapeutic inertia, Vol. 5. mHealth, China, p 1","DOI":"10.21037\/mhealth.2018.12.05"},{"issue":"7619","key":"5077_CR19","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1136\/bmj.39259.400069.AD","volume":"335","author":"B Guthrie","year":"2007","unstructured":"Guthrie B, Inkster M, Fahey T (2007) Tackling therapeutic inertia: role of treatment data in quality indicators. BMJ 335(7619):542\u2013544","journal-title":"BMJ"},{"key":"5077_CR20","unstructured":"Hebana KD, Bekele S (2022) iMedPub journals metabolic syndrome and its associated factors among adult patients attending outpatients clinics at Wolaita Sodo university comprehensive specialized hospital. Ethiopia 1\u201312"},{"issue":"1","key":"5077_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-020-04368-1","volume":"21","author":"X Huang","year":"2020","unstructured":"Huang X, Liu L, Song Y, Gao L, Zhao M, Bao H et al (2020) Achieving blood pressure control targets in hypertensive patients of rural China - a pilot randomized trial. Trials 21(1):515","journal-title":"Trials"},{"issue":"691","key":"5077_CR22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3399\/bjgp20X708053","volume":"70","author":"NR Jones","year":"2020","unstructured":"Jones NR, McCormack T, Constanti M, McManus RJ (2020) Diagnosis and management of hypertension in adults: NICE guideline update 2019. Br J Gen Pract 70(691):90\u201391","journal-title":"Br J Gen Pract"},{"issue":"12","key":"5077_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260403","volume":"16","author":"WP Kumma","year":"2021","unstructured":"Kumma WP, Lindtj\u00f8rn B, Loha E (2021) Prevalence of hypertension, and related factors among adults in Wolaita, southern Ethiopia: a community-based cross-sectional study. PLoS One 16(12):e0260403","journal-title":"PLoS One"},{"key":"5077_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-15-130","volume":"15","author":"J-P Lebeau","year":"2014","unstructured":"Lebeau J-P, Cadwallader J-S, Aubin-Auger I, Mercier A, Pasquet T, Rusch E et al (2014) The concept and definition of therapeutic inertia in hypertension in primary care: a qualitative systematic review. BMC Fam Pract 15:130","journal-title":"BMC Fam Pract"},{"issue":"4","key":"5077_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","volume":"16","author":"KT Mills","year":"2020","unstructured":"Mills KT, Stefanescu A, He J (2020) The global epidemiology of hypertension. Nat Rev Nephrol 16(4):223\u2013237","journal-title":"Nat Rev Nephrol"},{"key":"5077_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.cca.2016.12.014","volume":"465","author":"PM O\u2019Shea","year":"2017","unstructured":"O\u2019Shea PM, Griffin TP, Fitzgibbon M (2017) Hypertension: the role of biochemistry in the diagnosis and management. Clin Chim Acta 465:131\u2013143","journal-title":"Clin Chim Acta"},{"issue":"3","key":"5077_CR27","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s40256-021-00505-6","volume":"22","author":"A Pathak","year":"2022","unstructured":"Pathak A, Poulter NR, Kavanagh M, Kreutz R, Burnier M (2022) Improving the management of hypertension by tackling awareness, adherence, and clinical inertia: a symposium report. Am J Cardiovasc Drugs Drugs, Devices, Other Interv 22(3):251\u2013261","journal-title":"Am J Cardiovasc Drugs Drugs, Devices, Other Interv"},{"issue":"9","key":"5077_CR28","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-135-9-200111060-00012","volume":"135","author":"LS Phillips","year":"2001","unstructured":"Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL et al (2001) Clinical inertia. Ann Intern Med 135(9):825\u2013834","journal-title":"Ann Intern Med"},{"issue":"8","key":"5077_CR29","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1097\/HJH.0b013e32833b4953","volume":"28","author":"J Red\u00f3n","year":"2010","unstructured":"Red\u00f3n J, Coca A, L\u00e1zaro P, Aguilar MD, Caba\u00f1as M, Gil N et al (2010) Factors associated with therapeutic inertia in hypertension: validation of a predictive model. J Hypertens 28(8):1770\u20131777","journal-title":"J Hypertens"},{"issue":"5","key":"5077_CR30","first-page":"277","volume":"33","author":"CL Roumie","year":"2007","unstructured":"Roumie CL, Elasy TA, Wallston KA, Pratt S, Greevy RA, Liu X et al (2007) Clinical inertia: a common barrier to changing provider prescribing behavior. Jt Comm J Qual Patient Saf 33(5):277\u2013285","journal-title":"Jt Comm J Qual Patient Saf"},{"issue":"4","key":"5077_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-056627","volume":"12","author":"MM Sorato","year":"2022","unstructured":"Sorato MM, Davari M, Kebriaeezadeh A, Sarrafzadegan N, Shibru T (2022) Societal economic burden of hypertension at selected hospitals in southern Ethiopia: a patient-level analysis. BMJ Open 12(4):e056627","journal-title":"BMJ Open"},{"issue":"1","key":"5077_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-021-01934-6","volume":"21","author":"MM Sorato","year":"2021","unstructured":"Sorato MM, Davari M, Kebriaeezadeh A, Sarrafzadegan N, Shibru T, Fatemi B (2021) Reasons for poor blood pressure control in Eastern Sub-Saharan Africa: looking into 4P\u2019s (primary care, professional, patient, and public health policy) for improving blood pressure control: a scoping review. BMC Cardiovasc Disord 21(1):1\u201315","journal-title":"BMC Cardiovasc Disord"},{"key":"5077_CR33","unstructured":"Study O, Mba RD (2022) Modelling factors associated with therapeutic inertia in hypertensive patients. 49(September)"},{"issue":"12","key":"5077_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244642","volume":"15","author":"SA Tiruneh","year":"2020","unstructured":"Tiruneh SA, Bukayaw YA, Yigizaw ST, Angaw DA (2020) Prevalence of hypertension and its determinants in Ethiopia: a systematic review and meta-analysis. PLoS One 15(12):e0244642","journal-title":"PLoS One"},{"issue":"17","key":"5077_CR35","doi-asserted-by":"publisher","first-page":"e19769","DOI":"10.1097\/MD.0000000000019769","volume":"99","author":"F UndaVillafuerte","year":"2020","unstructured":"UndaVillafuerte F, LloberaC\u00e0naves J, Lorente Montalvo P, Moreno Sancho ML, Oliver Oliver B, Bassante Flores P et al (2020) Effectiveness of a multifactorial intervention, consisting of self-management of antihypertensive medication, self-measurement of blood pressure, hypocaloric and low sodium diet, and physical exercise, in patients with uncontrolled hypertension taking 2. Medicine (Baltimore) 99(17):e19769","journal-title":"Medicine (Baltimore)"},{"key":"5077_CR36","doi-asserted-by":"crossref","unstructured":"Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D et al (2020) International society of hypertension global hypertension practice guidelines. Hypertens (Dallas, Tex 1979) 75(6):1334\u201357","DOI":"10.1161\/HYPERTENSIONAHA.120.15026"},{"key":"5077_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2020.09.001","volume":"82","author":"P Verdecchia","year":"2020","unstructured":"Verdecchia P, Reboldi G, Angeli F (2020) The 2020 International Society of Hypertension global hypertension practice guidelines - key messages and clinical considerations. Eur J Intern Med 82:1\u20136","journal-title":"Eur J Intern Med"},{"issue":"33","key":"5077_CR38","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, AgabitiRosei E, Azizi M, Burnier M et al (2018) 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Eur Heart J 39(33):3021\u20133104","journal-title":"Eur Heart J"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05077-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05077-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05077-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T02:53:33Z","timestamp":1782096813000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05077-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["5077"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05077-3","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from Wolaita Sodo University\u2019s Institutional Review Board (IRB) under reference number CHSM\/ERC\/06\/15, along with permission from the hospital administration (CRCSD\/04\/2136\/2015). Written informed consent was obtained from all participants, and confidentiality was ensured by using medical record numbers instead of personal identifiers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent for publication of the study findings, including anonymized individual data, was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All participants provided written informed consent before taking part in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was obtained from Wolaita Sodo University\u2019s Institutional Review Board (IRB) under reference number CHSM\/ERC\/06\/15. Written informed consent was obtained from all participants.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate declarations"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Trial registration details"}}]}}